Combining functional features of whole-grain barley and legumes for dietary reduction of cardiometabolic risk: A randomised cross-over intervention in mature women

British Journal of Nutrition

Volumn 111, Issue 4, 2014, Pages 706-714

  Tovar, Juscelino ^a   Nilsson, Anne ^a   Johansson, Maria ^a   Björck, Inger ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Barley; Cardiovascular risk; Dietary prevention; Legumes

Indexed keywords

APOLIPOPROTEINS B; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, LDL; COLON; CROSS-OVER STUDIES; DIET; DIETARY FIBER; DRUG SYNERGISM; FABACEAE; FEMALE; FUNCTIONAL FOOD; GAMMA-GLUTAMYLTRANSFERASE; HORDEUM; HUMANS; HYDROGEN; MIDDLE AGED; OBESITY; PLANT PREPARATIONS; RISK FACTORS; SEEDS; TRITICUM;

APOLIPOPROTEIN B; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BARLEY; BODY WEIGHT; CARDIOMETABOLIC RISK; CHICKPEA; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; COLONIC FERMENTATIVE ACTIVITY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DIETARY COMPLIANCE; FEMALE; FRAMINGHAM RISK SCORE; GASTROINTESTINAL TRACT FUNCTION; HUMAN; HYDROGEN BREATH TEST; LEGUME; OBESITY; OUTCOME ASSESSMENT; PHASEOLUS VULGARIS; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SATIETY; TREATMENT DURATION;

HORDEUM;

EID: 84894117261     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711451300305X     Document Type: Article

References (50)

1. Feldeisen SE & Tucker KL (2007) Nutritional strategies in the prevention and treatment of metabolic syndrome. Appl Physiol Nutr Metab 32, 42-60.
2. Bruckert E & Rosenbaum D (2011) Lowering LDL-cholesterol through diet: potential role in the statin era. Curr Opin Lipidol 22, 43-48.
3. Adamsson V, Reumark A, Fredriksson IB, et al. (2011) Effects of a healthy Nordic diet on cardiovascular risk factors in hypercholesterolaemic subjects: a randomized controlled trial (NORDIET). J Intern Med 269, 150-159.
4. Estruch R, Mart?́nez-González MA, Corella D, et al. (2006) Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 145, 1-11.
5. Jenkins DJA, Kendall CWC, Faulkner D, et al. (2002) A dietary portfolio approach to cholesterol reduction: combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia. Metabolism 51, 1596-1604.
6. Tovar J, Nilsson A, Johansson M, et al. (2012) A diet based on multiple functional concepts improves cardiometabolic risk parameters in healthy subjects. Nutr Metab (Lond) 9, 29.
7. Jenkins DJ, Kendall CW, Faulkner DA, et al. (2006) Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. Am J Clin Nutr 83, 582-591.
8. Venn BJ, Perry T, Green TJ, et al. (2010) The effect of increasing consumption of pulses and whole grains in obese people: a randomized controlled trial. J Am Coll Nutr 29, 365-372.
9. Hutchins AM, Winham DM & Thompson SV (2012) Phaseolus beans: impact ion glycaemic response and chronic disease risk in human subjects. Br J Nutr 108, Suppl. 1, S52-S65.
10. Behall KM, Scholfield DJ & Hallfrisch J (2006) Whole-grain diets reduce blood pressure in mildly hypercholesterolemic men and women. J Am Diet Assoc 106, 1445-1449.
11. Björck I, Ostman E, Kristensen M, et al. (2012) Cereal grains for nutrition and health benefits: overview of results from in vitro, animal and human studies in the HEALTHGRAIN project. Trends Food Sci Technol 25, 87-100.
12. Nilsson A, Granfeldt Y, Ö stman E, et al. (2006) Effects of GI and content of indigestible carbohydrates of cereal-based evening meals on glucose tolerance at a subsequent standardized breakfast. Eur J Clin Nutr 60, 1092-1099.
13. Nilsson A, Ö stman E, Preston T, et al. (2008) Effects of GI vs content of cereal fibre of the evening meal on glucose tolerance at a subsequent standardized breakfast. Eur J Clin Nutr 62, 712-720.
14. Nilsson AC, Ostman EM, Holst JJ, et al. (2008) Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. J Nutr 138, 732-739.
15. Tovar J (1994) Bioavailability of carbohydrates in legumes. Digestible and indigestible fractions. Arch Latinoamer Nutr 44, 36S-40S.
16. Nilsson A, Johansson E, Ekström L, et al. (2013) Effects of a brown beans evening meal on metabolic risk markers and appetite regulating hormones at a subsequent standardized breakfast: a randomized cross-over study. PLoS ONE 8, e59985.
17. Nordic Council of Ministers (2004) Nutrition Recommendations 2004: Integrating Nutrition and Physical Activity, 4th ed. Copenhagen: Nordic Council of Ministers.
18. Friedewald WT, Levy RI & Fredriksson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499-502.
19. Matthews DR, Hosker JP, Rudenski AS, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
20. Asp NG, Johansson CG, Hallmer H, et al. (1983) Rapid enzymatic assay of insoluble and soluble dietary fibre. J Agric Food Chem 31, 476-482.
21. A kerberg AKE, Liljeberg HGM & Granfeldt Y (1998) An in vitro method, based on chewing, to predict resistant starch content in foods allows parallel determination of potentially available starch and dietary fibre. J Nutr 128, 651-659.
22. Anderson KM, Wilson PWF, Odell PM, et al. (1991) An updated coronary risk profile-a statement for healthprofessionals. Circulation 83, 356-362.
23. Eriksson L, Johansson E, Kettaneh-Wold N, et al. (2006) Multi-and Megavariate Data Analysis, Part II, Advanced Applications and Method Extensions, Chapter 23. Umea : Umetrics Academy.
24. Daryani A, Berglund L, Andersson A , et al. (2005) Risk factors for coronary heart disease among immigrant women from Iran and Turkey, compared to women of Swedish ethnicity. Ethn Dis 15, 213-220.
25. Foster-Powell K, Holt SHA & Brand-Miller JC (2002) International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr 76, 5-56.
26. Tovar J, Granfeldt Y & Björck I (1992) Effect of processing on blood-glucose response to starch in legumes. J Agric Food Chem 40, 1846-1851.
27. Nestel P, Cehun M & Chronopoulus A (2004) Effects of longterm consumption and single meals of chickpeas on plasma glucose, insulin and triacylglycerol concentrations. Am J Clin Nutr 79, 390-395.
28. Frost G, Leeds AA, Dore CJ, et al. (1999) Glycaemic index as a determinant of serum HDL-cholesterol concentration. Lancet 353, 1045-1048.
29. Sloth B, Krog-Mikkelsen I, Flint A, et al. (2004) No difference in body weight decrease between a low-glycemic-index and a high-glycemic-index diet but reduced LDL cholesterol after 10-wk ad libitum intake of the low-glycemic-index diet. Am J Clin Nutr 80, 337-347.
30. de Rougemont A, Normand S, Nazare JA, et al. (2007) Beneficial effects of a 5-week low-glycaemic index regimen on weight control and cardiovascular risk factors in overweight non-diabetic subjects. Br J Nutr 98, 1288-1298.
31. Biörklund M, van Rees A, Mensink RP, et al. (2005) Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with glucans from oats or barley: a randomised dose-controlled trial. Eur J Clin Nutr 59, 1272-1281.
32. Viuda-Martos M, Lopez-Marcos MC, Fernandez-Lopez J, et al. (2010) Role of fiber in cardiovascular diseases: a review. Compr Rev Food Sci Food Saf 9, 240-258.
33. Jenkins DJA, Kendall CWC, Vuksan V, et al. (2002) Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial. Am J Clin Nutr 75, 834-839.
34. Finley JW, Burrell JB & Reeves PG (2007) Pinto bean consumption changes SCFA profiles in fecal fermentations, bacterial populations of the lower bowel, and lipid profiles in blood of humans. J Nutr 137, 2391-2398.
35. Tovar J, Björck I & Asp N-G (1992) Incomplete digestion of legume starches in rats: a study of precooked flours containing retrograded and physically inaccessible starch fractions. J Nutr 122, 1500-1507.
36. Queiroz-Monici SK, Costa EAG, SilvaN, et al. (2005) Bifidogenic effect of dietary fiber and resistant starch from leguminous on the intestinal microbiota of rats. Nutrition 21, 602-608.
37. Martinez-Villaluenga C, Frias J & Vidal-Valverde C (2008) Alpha-galactosides: antinutritional factors or functional ingredients? Crit Rev Food Sci Nutr 48, 301-316.
38. Maathuis AJ, van den Heuvel EG, Schoterman MH, et al. (2012) Galacto-oligosaccharides have prebiotic activity in a dynamic in vitro colon model using a C-labeling technique. J Nutr 142, 1205-1212.
39. Mitsou EK, Panopoulou N, Turunen K, et al. (2010) Prebiotic potential of barley derived beta-glucan at low intake levels: a randomised, double-blinded, placebo-controlled clinical study. Food Res Int 43, 1086-1092.
40. Hernandez-Salazar M, Osorio-Diaz P, Loarca-Pina G, et al. (2010) In vitro fermentability and antioxidant capacity of the indigestible fraction of cooked blackbeans (Phaseolus vulgaris L.), lentils (Lens culinaris L.) and chickpeas (Cicer arietinum L.). J Sci Food Agric 90, 1417-1422.
41. Gamel T & Abdel-Aal EM (2012) Phenolic acids and antioxidant properties of barley wholegrain and pearling fractions. Agric Food Sci 21, 118-131.
42. Parkar SG, Stevenson DE & Skinner MA (2008) The potential influence of fruit polyphenols on colonic microflora and human gut health. Int J Food Microbiol 124, 295-298.
43. Fraser A, Harris R, Sattar N, et al. (2007) Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake analysis of the British women's heart and health study and meta-analysis. Arterioescler Thromb Vasc Biol 27, 2729-2735.
44. Montonen J, Drogan D, Joost H-G, et al. (2011) Estimation of the contribution of biomarkers of different metabolic pathways to risk of type 2 diabetes. Eur J Epidemiol 26, 29-38.
45. Liu C-F, Zhou W-N & Fang N-Y (2012) Gamma-glutamyltransferase levels and risk of metabolic syndrome: a meta-analysis of prospective cohort studies. Clin Pract 66, 692-698.
46. Aller R, De Luis DA, Izaola O, et al. (2011) Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver patients: a double blind randomized clinical trial. Eur Rev Med Pharmacol Sci 15, 1090-1095.
47. Franzini L, Ardigò D, Valtuena S, et al. (2012) Food selection based on high antioxidant capacity improves endothelial function in a low cardiovascular risk population. Nutr Metab Cardiovasc Dis 22, 50-57.
48. Gami AS, Witt BJ, Howard DE, et al. (2007) Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49, 403-414.
49. Rachas A, Raffaitin C, Barberger-Gateau P, et al. (2012) Clinical usefulness of the metabolic syndrome for the risk of coronary heart disease does not exceed the sum of its individual components in older men and women. The Three-City (3C) Study. Heart 98, 650-655.
50. Mehner A, Lindblad U, Rastam L, et al. (2008) Cholesterol in women at high cardiovascular risk is less successfully treated than in corresponding men. The Skaraborg Hypertension and Diabetes Project. Eur J Clin Pharmacol 64, 815-820.